rs370277502
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The ENST00000371117.8(PKHD1):c.274C>T(p.Arg92Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R92Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000371117.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKHD1 | NM_138694.4 | c.274C>T | p.Arg92Trp | missense_variant | 4/67 | ENST00000371117.8 | NP_619639.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKHD1 | ENST00000371117.8 | c.274C>T | p.Arg92Trp | missense_variant | 4/67 | 1 | NM_138694.4 | ENSP00000360158 | P2 | |
PKHD1 | ENST00000340994.4 | c.274C>T | p.Arg92Trp | missense_variant | 4/61 | 5 | ENSP00000341097 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251230Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135762
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461758Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727184
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74396
ClinVar
Submissions by phenotype
Autosomal recessive polycystic kidney disease Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Nov 23, 2018 | A heterozygous missense variant, NM_138694.3(PKHD1):c.274C>T, has been identified in exon 4 of 67 of the PKHD1 gene. The variant is predicted to result in a major amino acid change from arginine to tryptophan at position 92 of the protein (NP_619639.3(PKHD1):p.(Arg92Trp)). The arginine residue at this position has low conservation (100 vertebrates, UCSC), and is located within the IPT functional domain. In silico predictions of pathogenicity for this variant are conflicting (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD database at a frequency of 0.001% (3 heterozygotes, 0 homozygotes). An alternative residue change, p.(Arg92Gln) has been reported in the gnomAD database at a frequency of 0.07% (182 heterozygotes, 1 homozygote). The p.(Arg92Trp) variant has been previously described as pathogenic and segregated with disease in multiple families with Polycystic kidney disease (ClinVar, Gunay-Aygun, M. et al. (2010), Xu, Y. et al. (2014), Byun, YJ. et al. (2015), Schueler, M. et al (2016), PKHD1 Database). A different variant affecting the same amino acid resulting in a change to glycine has also been shown to cause Polycystic kidney disease (Bergmann, C. et al. (2005)). Based on the information available at the time of curation, this variant has been classified as PATHOGENIC. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 14, 2023 | Variant summary: PKHD1 c.274C>T (p.Arg92Trp) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251230 control chromosomes (gnomAD). c.274C>T has been reported in the literature in the compound heterozygous state in multiple individuals affected with Polycystic Kidney And Hepatic Disease (e.g. Gunay-Aygun_2010, Xu_2014, Byun_2015/Jung_2020, Wicher_2020, Jayasinghe_2021, Ishiko_2022). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 19914852, 34536170, 32939031, 32384486, 33282801, 25153916). Eight submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Seven submitters classified the variant as pathogenic/likely pathogenic and one classified it as uncertain significance. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Molecular Genetics, Children's Memorial Health Institute | Sep 25, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 92 of the PKHD1 protein (p.Arg92Trp). This variant is present in population databases (rs370277502, gnomAD 0.007%). This missense change has been observed in individual(s) with polycystic kidney disease (PMID: 19914852, 25153916, 32384486, 32939031, 33123899). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 286684). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PKHD1 protein function. For these reasons, this variant has been classified as Pathogenic. - |
Polycystic kidney disease 4 Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 19, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jun 30, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). Protein truncation variants are a common disease-causing mechanism. In silico tools do not predict the variant to alter splicing and produce an abnormal transcript (SpliceAI: 0.01). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000286684). A different missense change at the same codon (p.Arg92Gly) has been reported to be associated with PKHD1 related disorder (PMID: 15698423). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. - |
not provided Pathogenic:1Uncertain:1
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | Mar 28, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 14, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: Byun_2015_article, 30275481, 32939031, 19914852, 32384486, 25153916, 33282801) - |
PKHD1-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 03, 2023 | The PKHD1 c.274C>T variant is predicted to result in the amino acid substitution p.Arg92Trp. This variant alongside a pathogenic truncating PKHD1 variant has been reported in multiple individuals with autosomal recessive polycystic kidney disease (ARPKD) (Gunay-Aygun et al. 2010. PubMed ID: 19914852; Table S3, Jayasinghe et al. 2020. PubMed ID: 32939031; Jung et al. 2020. PubMed ID: 32384486). This variant has also been reported with another suspected pathogenic PKHD1 variant in a Chinese family with autosomal recessive polycystic kidney disease (ARPKD) (Xu et al. 2014. PubMed ID: 25153916). Of note, a different substitution at the same codon (p.Arg92Gly) has been reported in a patient with ARPKD (Bergmann et al. 2005. PubMed ID: 15698423). This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-51947197-G-A). This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at